Philip E. Lee

2.2k total citations
20 papers, 1.6k citations indexed

About

Philip E. Lee is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Philip E. Lee has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 7 papers in Economics and Econometrics and 4 papers in Pharmacology. Recurrent topics in Philip E. Lee's work include Dementia and Cognitive Impairment Research (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Schizophrenia research and treatment (5 papers). Philip E. Lee is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Schizophrenia research and treatment (5 papers). Philip E. Lee collaborates with scholars based in Canada and United States. Philip E. Lee's co-authors include Paula A. Rochon, Sudeep S. Gill, Susan E. Bronskill, Kathy Sykora, Sharon‐Lise T. Normand, Jerry H. Gurwitz, Nathan Herrmann, Muhammad Mamdani, George Anderson and Connie Marras and has published in prestigious journals such as Annals of Internal Medicine, Neurology and Journal of the American Geriatrics Society.

In The Last Decade

Philip E. Lee

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip E. Lee Canada	12	937	374	225	169	168	20	1.6k
Claire Chiang United States	17	939 1.0×	308 0.8×	188 0.8×	136 0.8×	190 1.1×	33	1.5k
Marjaana Koponen Finland	24	762 0.8×	520 1.4×	205 0.9×	198 1.2×	99 0.6×	81	1.6k
Megan E. Amuan United States	24	528 0.6×	397 1.1×	192 0.9×	129 0.8×	211 1.3×	67	1.7k
Sara García‐Ptacek Sweden	29	1.0k 1.1×	347 0.9×	197 0.9×	269 1.6×	351 2.1×	100	2.3k
Peijun Chen United States	18	1.1k 1.2×	361 1.0×	96 0.4×	208 1.2×	99 0.6×	53	2.2k
Che‐Sheng Chu Taiwan	24	653 0.7×	518 1.4×	242 1.1×	131 0.8×	111 0.7×	99	2.3k
Bruno Fantino France	27	805 0.9×	248 0.7×	151 0.7×	85 0.5×	91 0.5×	61	2.5k
Giulia Grande Sweden	28	923 1.0×	437 1.2×	247 1.1×	225 1.3×	126 0.8×	95	2.4k
Hedda Agüero‐Torres Sweden	18	1.0k 1.1×	313 0.8×	145 0.6×	108 0.6×	75 0.4×	24	2.0k
Mei Sian Chong Singapore	27	765 0.8×	403 1.1×	141 0.6×	176 1.0×	74 0.4×	75	2.0k

Countries citing papers authored by Philip E. Lee

Since Specialization

Citations

This map shows the geographic impact of Philip E. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Lee more than expected).

Fields of papers citing papers by Philip E. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Lee. The network helps show where Philip E. Lee may publish in the future.

Co-authorship network of co-authors of Philip E. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Lee. A scholar is included among the top collaborators of Philip E. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Lee. Philip E. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Best, John R., Philip E. Lee, Dean Foti, et al.. (2024). Clinical value of Alzheimer's disease biomarker testing. Alzheimer s & Dementia Translational Research & Clinical Interventions. 10(2). e12464–e12464. 1 indexed citations

Best, John R., Howard Feldman, Jacqueline A. Pettersen, et al.. (2022). Drug therapy, imaging, and other aspects of clinical management change after Alzheimer’s biomarker testing in routine practice: Findings from the IMPACT‐AD BC study. Alzheimer s & Dementia. 18(S6). 1 indexed citations

Barha, Cindy K., Ging‐Yuek Robin Hsiung, John R. Best, et al.. (2017). Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial. Journal of Alzheimer s Disease. 60(4). 1397–1410. 56 indexed citations

Sepehry, Amir A., Philip E. Lee, Ging‐Yuek Robin Hsiung, et al.. (2017). The 2002 NIMH Provisional Diagnostic Criteria for Depression of Alzheimer’s Disease (PDC-dAD): Gauging their Validity over a Decade Later. Journal of Alzheimer s Disease. 58(2). 449–462. 14 indexed citations

Lee, Philip E., et al.. (2017). Prevalence of delusions in drug‐naïve Alzheimer disease patients: A meta‐analysis. International Journal of Geriatric Psychiatry. 34(9). 1287–1293. 5 indexed citations

Lee, Philip E., Mary C. Tierney, Wei Wu, Kathleen I. Pritchard, & Paula A. Rochon. (2016). Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Research and Treatment. 158(3). 407–420. 45 indexed citations

Liu‐Ambrose, Teresa, John R. Best, Jennifer C. Davis, et al.. (2016). Aerobic exercise and vascular cognitive impairment. Neurology. 87(20). 2082–2090. 111 indexed citations

Brinke, Lisanne F. ten, Chun Liang Hsu, Niousha Bolandzadeh, et al.. (2015). P2‐297: Aerobic exercise increases cortical white matter volume in older adults with vascular cognitive impairment: A 6‐month randomized controlled trial. Alzheimer s & Dementia. 11(7S_Part_13). 1 indexed citations

Sepehry, Amir A., Philip E. Lee, Ging‐Yuek Robin Hsiung, B. Lynn Beattie, & Claudia Jacova. (2012). Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression. Drugs & Aging. 29(10). 793–806. 78 indexed citations

10.

Wong, Camilla L., Nick Bansback, Philip E. Lee, & Aslam H. Anis. (2009). Cost-Effectiveness: Cholinesterase Inhibitors and Memantine in Vascular Dementia. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 36(6). 735–739. 11 indexed citations

11.

Gill, Sudeep S., Susan E. Bronskill, Sharon‐Lise T. Normand, et al.. (2007). Antipsychotic Drug Use and Mortality in Older Adults with Dementia. Annals of Internal Medicine. 146(11). 775–786. 452 indexed citations

12.

Lee, Philip E., Sudeep S. Gill, & Paula A. Rochon. (2006). Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia. Neuropsychiatric Disease and Treatment. 2(4). 521–529. 5 indexed citations

13.

Lee, Philip E., Janet E. McElhaney, & Larry Dian. (2006). Calcium and Vitamin D Supplementation for the Prevention of Fractures in Postmenopausal Women. Aging Health. 2(2). 241–243. 1 indexed citations

14.

Gill, Sudeep S., Connie Marras, Geoffrey M. Anderson, et al.. (2006). Atypical Antipsychotics Have Very Different Adverse Effect Profiles and Should Not Be Lumped Together—Reply. Archives of Internal Medicine. 166(5). 586–586.

15.

Gill, Sudeep S., Muhammad Mamdani, Gary Naglie, et al.. (2005). A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs. Archives of Internal Medicine. 165(7). 808–808. 166 indexed citations

16.

Gill, Sudeep S., Paula A. Rochon, Nathan Herrmann, et al.. (2005). Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ. 330(7489). 445–445. 237 indexed citations

17.

Rochon, Paula A., Thérèse A. Stukel, Kathy Sykora, et al.. (2005). Atypical Antipsychotics and Parkinsonism. Archives of Internal Medicine. 165(16). 1882–1882. 126 indexed citations

18.

Lee, Philip E., Kathy Sykora, Sudeep S. Gill, et al.. (2005). Antipsychotic Medications and Drug‐Induced Movement Disorders Other Than Parkinsonism: A Population‐Based Cohort Study in Older Adults. Journal of the American Geriatrics Society. 53(8). 1374–1379. 64 indexed citations

19.

Shulman, Kenneth I., Kathy Sykora, Sudeep S. Gill, et al.. (2005). New Thyroxine Treatment in Older Adults Beginning Lithium Therapy: Implications for Clinical Practice. American Journal of Geriatric Psychiatry. 13(4). 299–304. 21 indexed citations

20.

Lee, Philip E., Sudeep S. Gill, Morris Freedman, et al.. (2004). Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ. 329(7457). 75–75. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact